Activation of the HIV type 1 long terminal repeat by X-irradiation involves two main Rel/NF-κB DNA-binding complexes

AIDS Research and Human Retroviruses

Volumn 12, Issue 16, 1996, Pages 1519-1527

  Faure, Eric ^a   Lecine, Patrick ^b   Imbert, Jean ^b   Champion, Serge ^c  

^a Université de Provence   (France)

^b INSTITUT PAOLI CALMETTES   (France)

^c CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; GENE ACTIVATION; HUMAN IMMUNODEFICIENCY VIRUS 1; LONG TERMINAL REPEAT; NONHUMAN; PRIORITY JOURNAL; REPORTER GENE; TRANSCRIPTION REGULATION; VIRUS GENE; X IRRADIATION;

EID: 0029909588     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1996.12.1519     Document Type: Article

References (60)

1. Peterlin BM, Luciw PA, Barr PJ, and Walker MD: Elevated levels of mRNA can account for the trans-activation of human immunodeficiency virus. Proc Natl Acad Sci USA 1986;83: 9734-9738.
2. Valerie K, Delers A, Bruck C, Thiriart C, Rosenberg H, Debouck C, and Rosenberg M: Activation of human immunodeficiency virus type 1 by DNA damage in human cells. Nature (London) 1988; 333:78-81.
3. Rosenberg ZF and Fauci AS: Induction of expression of HIV in latently or chronically infected cells. AIDS Res Hum Retroviruses 1989;5:1-4.
4. Cavard C, Zider A, Vernet M, Bennoun M, Saragosti S, Grimber G, and Briand P: In vivo activation by ultraviolet rays of the human immunodeficiency virus type 1 long terminal repeat. J Clin Invest 1990;86:1369-1374.
5. Zmudza BZ and Beer JZ: Activation of human immunodeficiency virus by ultraviolet radiation. Photochem Photobiol 1990;52: 1153-1162.
6. Zider A, Mashhour B, Fergelot P, Grimber G, Vernet M, Hazan U, Couton D, Briand P, and Cavard C: Dispensable role of the NF-κB sites in the UV-induction of the HIV-1 LTR in transgenic mice. Nucleic Acids Res 1993;21:79-86.
7. Nokta M, Belli J, and Pollard R: X-Irradiation enhances in vitro human immunodeficiency virus replication correlation with cellular levels of cAMP. Proc Soc Exp Biol Med 1992;200:402-408.
8. Libertin CR, Panozzo J, Groth KR, Chang-Liu C-M, Schreck S, and Woloschak GE: Effects of gamma rays, ultraviolet radiation, sunlight, microwaves and electromagnetic fields on gene expression mediated by human immunodeficiency virus promoter. Radiat Res 1994;140:91-96.
9. Vicenzi E and Poli G: Ultraviolet irradiation and cytokines as regulators of HIV latency and expression. Chem Biol Interact 1994;91:101-109.
10. Woloschak GE, Chang-Liu CM, Panozzo J, and Libertin CR: Low doses of neutrons induce changes in gene expression. Radiat Res 1994;138:S56-S59.
11. Fornace AJ Jr: Mammalian genes induced by radiation; activation of genes associated with growth control. Annu Rev Genet 1992;26:507-526.
12. Herrlich P, Ponta H, and Rahmsdorf HJ: DNA damage-induced gene expression: Signal transduction and relation to growth factor signaling. Rev Physiol Biochem Phanmacol 1992;119:187-223.
13. Herrlich P and Rahmsdorf HJ: Transcriptional and post-transcriptional responses to DNA-damaging agents. Curr Opin Cell Biol 1994;6:425-431.
14. Sherman ML, Datta R, Hallahan DE, Weichselbaum RR, and Kufe DW: Ionizing radiation regulates expression of the c-jun protooncogene. Proc Nalt Acad Sci USA 1990;87:5663-5666.
15. Hallahan DE, Sukhatme VP, Sherman ML, Virudachalam S, Kufe D, and Weichselbaum RR: Protein kinase C mediates X-ray inducibility of nuclear transducers EGR 1 and JUN. Proc Natl Acad Sci USA 1991;88:2156-2160.
16. Brach MA, Hass R, Sherman ML, Gunji H, Weichselbaum R, and Kufe D: Ionizing radiation induces expression and binding activity of the nuclear factor-κB. J Clin Invest 1991;88:691-695.
17. Schreck R, Meier B, Mannel D, Droge W, and Baeuerle PA: Dithiocarbamates as potent inhibitors of the nuclear factor κB activation in intact cells. J Exp Med 1992;175:1181-1194.
18. Brach MA, Gruss HJ, Kaisho T, Asano Y, Hirano T, and Herrmann F: Ionizing radiation induces expression of interleukin 6 by human fibroblasts involving activation of nuclear factor-kappa B. J Biol Chem 1993;268:8466-8472.
19. Mohan N and Meltz ML: Induction of nuclear factor kappa B after low-dose ionizing radiation involves a reactive oxygen intermediate signaling pathway. Radiat Res 1994;140:97-104.
20. Prasad AV, Mohan N, Chandrasekar B, and Meltz ML: Activation of nuclear factor kappa B in human lymphoblastoid cells by low-dose ionizing radiation. Radiat Res 1994;138:367-372.
21. Baeuerle PA and Baltimore D: IκB: A specific inhibitor of the NF-κB transcription factor. Cell 1988;49:729-739.
22. Baeuerle PA and Henkel T: Function and activation of NF-κB in the immune system. Annu Rev Immunol 1994;12:141-179.
23. Nolan GP and Baltimore D: The inhibitory ankyrin and activator Rel proteins. Curr Opin Genet Dev 1992;2:211-220.
24. Blank V, Kourilsky P, and Israel A: NF-kappa B and related proteins: Rel/dorsal homologies meet ankyrin-like repeats. Trends Biochem Sci 1992;17:135-140.
25. Nabel G and Baltimore D: An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature (London) 1987;326:711-713.
26. Dinter HR, Chiu M, Imagawa M, Karin M, and Jones KA: In vitro activation of the HIV-1 enhancer in extracts from cells treated with a phorbol ester tumor promoter. EMBO J 1987;6:4067-4071.
27. Faure E, Cavard C, Zider A, Guillet J-P, Resbeut M, and Champion S: X irradiation-induced transcription from the HIV type 1 long terminal repeat. AIDS Res Hum Retroviruses 1995;11:41-43.
28. Jones KA, Kadonaga JT, Luciw PA, and Tijan R: Activation of the AIDS retrovirus promoter by the cellular transcription factor Sp1. Science 1986;232:755-759.
29. Perkins ND, Agranoff AB, Duckett CS, and Nabel GJ: Transcription factor AP-2 regulates human immunodeficiency virus type 1 gene expression. J Virol 1994;68:6820-6823.
30. Gaynor R: Cellular transcription factors involved in the regulation of HIV-1 gene expression. AIDS 1992;6:347-363.
31. Costello R, Lecine P, Kahn-Perles B, Algarté M, Lipcey C, Olive D, and Imbert J: Rel/NF-kappa B transcription factor: Activation and regulation. M/S Med Sci 1995;11:957-965.
32. Leonard J, Parrot C, Buckler-White A, Turner W, Ross EK, Martin MA, and Rabson AB: The NF-κB binding sites in the human immunodeficiency virus type 1 long terminal repeat are not required for virus infectivity. J Virol 1989;63:4919-4924.
33. Fogh J and Trempe G: New human tumor cell lines. In: Human Tumor Cell Line in Vitro (Fogh J, Ed.). Plenum Press, New York, 1975, pp. 115-159.
34. Sambrook J, Fritsch EF, and Maniatis T: Molecular Cloning. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, 1989.
35. Gorman CM, Moffat LF, and Howard BH: Recombinant genomes which express chloramphenicol acetyl-transferase in mammalian cells. Mol Cell Biol 1982;2:1044-1051.
36. Schreiber E, Mathias P, Muller MM, and Schaffner W: Rapid detection of octomer binding proteins with "mini extracts" prepared from a small number of cells. Nucleic Acids Res 1989;17: 6419-6423.
37. Staal FJ, Roederer M, and Herzenberg LA: Intracellular thiols regulate activation of nuclear factor κB and transcription of human immunodeficiency virus. Proc Natl Acad Sci USA 1990;87: 9943-9947.
38. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254.
39. Bachelerie F, Alcami J, Arenzana-Seisdedos F, and Virelizier J-L: HIV enhancer activity perpetuated by NF-κB induction on infection of monocytes. Nature (London) 1991;350:709-711.
40. Molitor JA, Walker WH, Doerre S, Ballard DW, and Greene WC: NF-κB A family of inducible and differentially expressed enhancer-binding proteins in human T cells. Proc Natl Acad Sci USA 1990;87:10028-10032.
41. Schreck R, Rieber P, and Baeuerle PA: Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1. EMBO J 1991;10: 2243-2258.
42. Kieran M, Blank V, Logeat F, Vandekerckhov J, Lottspeich F, Le-Bail O, Urban MB, Kourilsky P, Baeuerle PA, and Israel A: The DNA binding subunit of NF-κB is identical to factor KBF1 and homologous to the rel oncogene product. Cell 1990;62: 1007-1018.
43. Tewari M, Dobranski P, Mohn KL, Cressman DE, Hsu J-C, Brav R, and Taub R: Rapid induction in regenerating liver of RL/IF-1 (and IκB that inhibits NF-κB, RelB-p50, and c-Rel-p50) and PHF, a novel κB site binding complex. Mol Cell Biol 1992; 12:2898-2908.
44. Beg AA and Baldwin AS Jr: Activation of multiple NF-κB/Rel DNA-binding complexes by tumor necrosis factor. Oncogene 1994;9:1487-1492.
45. Kunsch C, Ruben SM, and Rosen CA: Selection of optimal κB/Rel DNA binding motifs: Interaction of both subunits of NFκB with DNA is required for transcriptional activation. Mol Cell Biol 1992;12:4412-4421.
46. Franzoso G, Bours V, Park S, Tomita-Yamaguchi M, Kelly K, and Siebenlist U: The candidate oncoprotein Bcl-3 is an antagonist of p50/NF-κB-mediated inhibition. Nature (London) 1992;359: 339-342.
47. Kang SM, Tran AC, Grilli M, and Lenardo MJ: NF-κB subunit regulation in nontransformed CD4+ T-lymphocytes. Science 1992;256:1452-1456.
48. Schmitz ML and Baeuerle PA: The p65 subunit is responsible for the strong transcription activating potential of NF-κB. EMBO J 1'992;11:3805-3817.
49. Costello R, Lipcey C, Algarté M, Cerdan C, Baeuerle PA, Olive D, and Imbert J: Activation of primary human T-lymphocytes through CD2 plus CD28 adhesion molecules induces long-term nuclear expression of NF-kappa B, Cell Growth Different 1993; 4:329-339.
50. Oakes JW, Bagasra O, Duan L, and Pomerantz RJ: Association of allemations in NF-κB moities with HIV type 1 proviral latency in certain monocytic cells. AIDS Res Hum Retroviruses 1994; 10:1213-1219.
51. Lenardo MJ, Fan C-M, Maniatis T, and Baltimore D: The involvement of NF-κB in β Interferon gene regulation reveals its role as widely inducible mediation of signal transduction. Cell 1991;57:287-294.
52. Sen R and Baltimore D: Inducibility of κ immunoglobin enhancerbinding protein NF-κB by a posttranslational mechanism. Cell 1986;47:921-928.
53. Rauth AM: In: The Basic Science of Oncology (Tannock IF and Hill RP, Eds.). Pergamon Press, Elmsford, New York, 1987, pp. 106-124.
54. Legrand-Poels S, Vaira D, Pincemail J, Van de Vorst A, and Piette J: Activation of human immunodeficiency virus type 1 by oxidative stress. AIDS Res Hum Retroviruses 1990;6:1389-1394.
55. Burdach S, Zessack N, Dilloo D, Shatsky M, Thompson D, and Levitt L: Differential regulation of lymphokine production by distinct subunits of the T cell interleukin 2 receptor. J Clin Invest 1991;87:2114-2121.
56. Kumar S, Rabson AB, and Gelinas C: The RxxRxRxxC motif conserved in all Rel/κB proteins is essential for the DNA-binding activity and redox regulation of the v-Rel oncoprotein. Mol Cell Biol 1992;12:3094-3106.
57. Lin CS, Goldthwait DA, and Samols D: Induction of transcription from the long terminal repeat of Moloney murine sarcoma provirus by UV-irradiation, X-irradiation and phorbol ester. Proc Natl Acad Sci USA 1990;87:36-40.
58. Ghosh S and Baltimore D: Activation in vitro of NF-κB by phosphorylation of its inhibitor IκB. Nature (London) 1990;344: 678-682.
59. Valerie K, Laster WS, Kirkhamn JC, and Kuemmerle NB: Ionizing radiation activates nuclear kappa B but fails to produce an increase in human immunodeficiency virus gene expression in stably transfected human cells. Biochemistry 1995;34:15768-15776.
60. Reisinger EC, Kern P, Ernst M, Bock P, Flad HD, Dietrich M, and German DTC Study Group 1990: Inhibition of HIV progression by dithiocarbamates. Lancet 1990;335:679-682.